SCHEMBL25528657

SCHEMBL25528657

CC(=O)COc1cc(Cl)c(Cc2ccc(O)c(Cc3ccc(Cl)cc3)c2)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 6/20 0.55
THRB P10828 6/20 0.55
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CYP3A4 P08684 2/20 0.41
HPGD P15428 2/20 0.41
ALOX15 P16050 2/20 0.41
HIF1A Q16665 2/20 0.41
HSD17B10 Q99714 1/20 0.41
MAOA P21397 3/20 0.40
MAOB P27338 3/20 0.40
MAPT P10636 2/20 0.38
SLC7A5 Q01650 1/20 0.38
SLC22A1 O15245 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
HSP90AA1 P07900 1/20 0.37
HSPD1 P10809 1/20 0.37
HSPA5 P11021 1/20 0.37
IDO1 P14902 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25528658 0.92 THRB (0.54) THRATHRBMEN1KMT2ACYP3A4
SCHEMBL25528726 0.92 THRA (0.56) THRATHRBMEN1KMT2ACYP3A4
SCHEMBL25528612 0.91 THRA (0.53) THRATHRBMEN1KMT2AMAOA
SCHEMBL25528646 0.90 THRA (0.52) THRATHRBCYP3A4MAPTSLC7A5
SCHEMBL23003709 0.89 THRB (0.65) THRATHRBMEN1KMT2ACYP3A4
SCHEMBL23003769 0.89 THRA (0.53) THRATHRBMEN1KMT2ACYP3A4
SCHEMBL25528664 0.88 THRB (0.50) THRATHRBMEN1KMT2ACYP3A4
SCHEMBL25528638 0.88 THRA (0.50) THRATHRBMAPTSLC7A5HSP90AA1
SCHEMBL25528661 0.87 THRB (0.51) THRATHRBKMT2ASLC7A5
SCHEMBL25528689 0.86 THRB (0.50) THRATHRBHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR THRA 4/4885THRB 9/4885MEN1 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.